Bay Street News, September, 2020

Abstracts to Focus on:Results from Phase 2, Open-Label, Multicenter, 2×2 Cross-Over Trial to Assess Safety and Efficacy of MS1819 in […]

CAMBRIDGE, Mass., Sept. 15, 2020 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA, “Momenta” or the “Company”), a biotechnology company focused […]

– Corporate restructuring to extend cash runway through mid-2022 and key milestones –– UBX1325 to enter clinical development in patients […]

MELBOURNE, Australia, Sept. 15, 2020 (GLOBE NEWSWIRE) — Molecular diagnostics company Genetic Technologies Limited (ASX: GTG, NASDAQ:GENE) (“Genetic Technologies” or […]

VANCOUVER, British Columbia, Sept. 15, 2020 (GLOBE NEWSWIRE) — Liquid Media Group Ltd. (the “Company”, “Liquid Media” or “Liquid”) (Nasdaq: […]

Partnership secures access to cGMP capacity and resources at Viralgen to support the development and commercialization of Axovant’s AAV gene […]

NOT FOR DISTRIBUTION IN THE U.S. OR OVER U.S. NEWSWIRES           HALIFAX, Nova Scotia and VANCOUVER, British […]

VANCOUVER, British Columbia, Sept. 15, 2020 (GLOBE NEWSWIRE) — Cornish Metals Inc. (TSX-V: CUSN) (“Cornish Metals” or the “Company”) is […]

VANCOUVER, British Columbia , Sept. 15, 2020 (GLOBE NEWSWIRE) — Prosper Gold Corp. (“Prosper Gold” or the “Company”) (TSXV: PGX) […]

MARKHAM, Ontario, Sept. 15, 2020 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has […]